TB-500, and the volatility it shares with its category.
Usually considered alongside BPC-157, and subject to the same regulatory movement — which means the same planning discipline.
What it is
TB-500 is a synthetic peptide related to a fragment of thymosin beta-4. It sits in the recovery and tissue category, most often considered alongside BPC-157. It is a compounded preparation dispensed against a prescription and is not an approved drug product.
Same category, same volatility
TB-500 has been subject to the same bulk-substance category movement that affects the rest of the recovery group. The planning consequence is identical: a clinic should not build menu economics that depend on it remaining available, and should have a substitution path decided before it is needed rather than during a shortage.
Which pharmacy path applies
Typically 503(a) patient-specific compounding, with the same lead-time consequence for patient scheduling as the rest of that path.
Menu fit
Clinics carrying it usually carry the recovery category as a unit rather than as separate lines, which simplifies both the patient conversation and the inventory position. Packaging the category rather than the compound also insulates the menu somewhat if one member of it becomes unavailable.
This library is written for clinic operators making menu, sourcing and inventory decisions. It is not medical advice, contains no dosing or protocol guidance, and makes no claim about the safety or effectiveness of any compounded preparation. Compounded medications are not FDA-approved. What any individual patient should receive is a decision for a licensed practitioner.
TB-500 questions.
Should we carry it alongside BPC-157?
How exposed are we if it becomes unavailable?
Your patients are already asking about peptides.Make sure your clinic is ready to answer.
Build and launch your peptide program with Revival RX Partners in 90 days.
Important
- Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
- All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
- Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
- Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.